|
UBTD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.762800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.375300E-03 |
| Normal-vs-Stage2 |
1.895870E-02 |
| Normal-vs-Stage3 |
2.615800E-01 |
| Normal-vs-Stage4 |
9.427600E-01 |
| Stage1-vs-Stage2 |
5.126400E-01 |
| Stage1-vs-Stage3 |
5.258400E-01 |
| Stage1-vs-Stage4 |
4.597800E-01 |
| Stage2-vs-Stage3 |
3.255400E-01 |
| Stage2-vs-Stage4 |
3.395800E-01 |
| Stage3-vs-Stage4 |
6.210800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.526240E-02 |
| Normal-vs-AfricanAmerican |
4.784900E-03 |
| Normal-vs-Asian |
1.611210E-01 |
| Caucasian-vs-AfricanAmerican |
3.951000E-01 |
| Caucasian-vs-Asian |
8.675000E-01 |
| AfricanAmerican-vs-Asian |
9.179800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.357470E-03 |
| Normal-vs-Female |
3.717200E-01 |
| Male-vs-Female |
4.094100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.330260E-02 |
| Normal-vs-Extreme_Weight |
2.657900E-03 |
| Normal-vs-Obese |
1.437620E-01 |
| Normal-vs-Extreme_Obese |
2.997500E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.673200E-01 |
| Normal_Weight-vs-Obese |
1.610380E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.636400E-01 |
| Extreme_Weight-vs-Obese |
1.533750E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.114800E-01 |
| Obese-vs-Extreme_Obese |
3.255800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.710500E-02 |
| Normal-vs-Age(41-60Yrs) |
3.144800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.615100E-04 |
| Normal-vs-Age(81-100Yrs) |
1.957950E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.788800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.508000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.342000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.704500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.591600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.844200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.302600E-03 |
| Normal-VS-Type2 PRCC |
6.382800E-03 |
| Normal-VS-KIRP CIMP |
2.425600E-02 |
| Normal-VS-Unclassified PRCC |
6.801200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.823200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.004600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.786400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.313000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.209630E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.600200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.424100E-04 |
| Normal-vs-N1 |
9.600600E-01 |
| Normal-vs-N2 |
8.476200E-03 |
| N0-vs-N1 |
6.992100E-02 |
| N0-vs-N2 |
4.389000E-01 |
| N1-vs-N2 |
2.297200E-01 |
|
|
